Transactions

Peterson & Co. acts for Revive Therapeutics Ltd. in Rights Offering

On May 16, 2016, Revive Therapeutics Ltd. (TSXV:  RVV) announced a best efforts rights offering to raise $2.2 million.  Revive is focused on commercializing treatments for gout, and rare diseases such as cystinuria, Wilson’s disease and Rett syndrome.

Back

Recent Transactions

15 March 2023

Peterson McVicar Acts for Foran in Upsize to Previously Announced Brokered Private Placement to C$100 Million

Learn More

13 March 2023

Peterson McVicar Acts for Probe Gold in $15 Million Bought Deal Private Placement

Learn More

13 February 2023

Peterson McVicar Acts for Red Cloud in C$5.0M Bought Deal Private Placement and Concurrent Non-Brokered Private Placement of C$2.0 Million with Brunswick Exploration

Learn More

13 February 2023

Peterson McVicar Acts for Red Cloud in C$5.0M Bought Deal Private Placement and Concurrent Non-Brokered Private Placement of C$2.0 Million with Brunswick Exploration

Learn More